Aktuelle Kurse von Anbio Biotechnology - Class A Ordinary Shares

Börse	Ticker	Währung	Letzter Umsatz	Kurs	Tagesveränderung
NASDAQ	NNNN	USD	31.07.2025 22:37	45,00 USD	3,20 USD +7,66 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	-12,62 %	41,67 %	618,85 %	548,41 %	548,41 %	548,41 %

Company Profile for Anbio Biotechnology - Class A Ordinary Shares Share

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.

Company Data

Name Anbio Biotechnology - Class A Ordinary Shares

Company Anbio Biotechnology Class A Ordinary Shares

Symbol NNNN

Website https://www.anbio.com

Primary Exchange

NASDAQ

ISIN KYG0367B1059

Asset Class Share

Sector Healthcare

Industry Medical - Instruments & Supplies

CEO Mr. Michael Lau M.B.A., Ph.D.

Market Capitalization 365 Mio

Country Germany

Currency USD

Employees 0,0 T

Address Wilhelm Gutbrod Str 21B, 60437 Frankfurt am Main

IPO Date 2025-02-19

Ticker Symbols

Name	Symbol
Frankfurt	N3B.F
NASDAQ	NNNN

More Shares

Investors who hold Anbio Biotechnology - Class A Ordinary Shares also have the following shares in their portfolio:

KROGER CO 12/22 Bond

RACKSPACE TECHNOLOGIESLOGY INC Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog